Best Warren Buffett Stocks To Buy Right Now

Warren Buffett may not have supported Donald Trump’s candidacy for president, but the 86-year-old billionaire certainly benefited from the unexpected outcome.

Stocks are up across the board since the presidential election, boosting the value of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio, but few stocks have rallied as much as Bank of America (NYSE:BAC).

The Bank of America building dominates the Dallas skyline. Image source: Getty Images.

In 2011, during the darkest days of Bank of America’s struggle to survive the fallout from the financial crisis, Buffett called the bank’s CEO Brian Moynihan with an idea. Buffett would inject $5 billion of Berkshire Hathaway’s cash into Bank of America, giving the bank a much-needed seal of approval.

But the deal had to be done on highly favorable terms to Berkshire Hathaway. Buffett demanded $5 billion worth of preferred stock yielding 6%, or $300 million a year. On top of that, the bank kicked in warrants to buy 700 million shares of Bank of America stock for $7.14 per share, exercisable at any time before the middle of 2021.

Best Warren Buffett Stocks To Buy Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap women’s health therapeutic stock Juniper Pharmaceuticals (NASDAQ: JNP):

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):

    Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a hurry. If you’re not it at the time it happens, you may not be able to get in at a decent price.

Best Warren Buffett Stocks To Buy Right Now: STARWOOD PROPERTY TRUST, INC.(STWD)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Starwood Property Trust (STWD) is a finance REIT, which means it makes or owns real estate mortgages rather than owning commercial property. The bulk of Starwood Property’s business is to make and hold commercial property mortgages.

Best Warren Buffett Stocks To Buy Right Now: Hibbett Sports Inc.(HIBB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Hibbett Sports, Inc. (NASDAQ: HIBB) were down 12 percent to $39.75 after the company reported weaker-than-expected earnings for its third quarter.

  • [By Paul Ausick]

    Hibbett Sports Inc. (NASDAQ: HIBB) posted a new 52-week low of $13.30 on Monday, down about 33% from Friday’s closing price of $19.70. Volume totaled around 6.7 million shares, about 13 times the daily average of around 550,000. The company issued a profit warning this morning and a late e-commerce launch.

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Mark Balson]

    Hibbett Sports (HIBB) financial results have come out with better than expected earnings for the fiscal 2017 first quarter.

    Revenue for the first quarter was $282.09 million which is 4.6% higher to year on year data. This is below expectations for analysts who were projected revenue to be at $285.15 million. Compare to 0.9% decline in net sales last year this year store sales increased 1.1%. 

Best Warren Buffett Stocks To Buy Right Now: Hudson Technologies, Inc.(HDSN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hudson Technologies, Inc. (NASDAQ: HDSN) shares dropped 13 percent to $6.55 amid concerning guidance. The company said it is expecting Q3 EPS of $0.03-$0.05 versus an analyst consensus estimate of $0.10. Sales are expected to be around $25 million versus the analyst estimate of nearly $41 million.

  • [By WWW.THESTREET.COM]

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

Best Warren Buffett Stocks To Buy Right Now: SPDR S&P MidCap 400 ETF (MDY)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Cougar Global Investments Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cougar+Global+Investments+Ltd

    These are the top 5 holdings of Cougar Global Investments LtdSPDR MidCap Trust Series I (MDY) – 134,036 shares, 37.74% of the total portfolio. Shares added by 9.81%SPDR S&P 500 (SPY) – 150,252 shares, 31.92% of the total portfolio. Shares added by 359.35%iShares Core S&P Small-Cap (IJR) – 374,523 shares, 23.35% of the total portfolio. Shares added by 283.37%iShares MBS (MBB) – 37,334 shares, 3.59% of the total portfolio. Shares added by 109.88%iShares Core U.S. Aggregate Bond (AGG) – 34,781 shares, 3.4% of the

  • [By WWW.GURUFOCUS.COM]

    For the details of REGENTS OF THE UNIVERSITY OF CALIFORNIA’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=REGENTS+OF+THE+UNIVERSITY+OF+CALIFORNIA

    These are the top 5 holdings of REGENTS OF THE UNIVERSITY OF CALIFORNIAiShares J.P. Morgan USD Emerging Markets Bond ETF (EMB) – 229,390 shares, 55.6% of the total portfolio. New PositionThe Estee Lauder Companies Inc (EL) – 33,400 shares, 7.5% of the total portfolio. Exxon Mobil Corp (XOM) – 33,600 shares, 5.74% of the total portfolio. SPDR MidCap Trust Series I (MDY) – 5,600 shares, 3.8% of the total portfolio. New PositionAir Products & Chemicals Inc (APD) – 10,200 shares, 3.21% of the total portfolio. New Purch

Best Warren Buffett Stocks To Buy Right Now: MannKind Corporation(MNKD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Peter Graham]

    Small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) reportedQ1 2017 earnings after the Thursday market close.The Companysnovel rapid-acting inhaled insulin therapy Afrezza has generally been a disappointment for investors with the stock havingelevated short interest of 38.86% according to Highshortinterest.com.

  • [By WWW.MONEYSHOW.COM]

    MannKind Corp. (MNKD) has developed a drug, Afrezza, which is a new form of inhalable insulin that is proving to have many benefits over existing mealtime insulins for diabetics.  

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell 0.48 percent. Meanwhile, top losers in the sector included MannKind Corporation (NASDAQ: MNKD), down 10 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) down 10 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *